Hjem › Aterosklerose › Indiana
Aterosklerose kliniske forsøg i Indiana
8 studier for Aterosklerose søger deltagere på steder i Indiana.
Byer i Indiana
Officiel studietekst (engelsk)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Asha Clinical Research-Munster,Llc, Hammond
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- IU Health Bloomington, Bloomington
- Indiana University Health Methodist Hospital, Indianapolis
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Cardiovascular Research of Northwest Indiana LLC, Munster
- Velocity Clinical Research - Valparaiso, Valparaiso
RekruttererFase 3
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- NANI Research, Fort Wayne
- Nephrology Physician's LLC, Mishawaka
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Evansville
- Research Site, Evansville
- Research Site, Indianapolis
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- American Health Network Research Dept, Muncie
- American Health Network Research Dept, Muncie
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 7. aug. 2026 · NCT06813911Pharmacogenomic Informed Statin Prescribing
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Rekrutterer
Alder 40 til 75 · Alle køn · Opdateret 13. apr. 2026 · NCT06568601Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.